Artificial Intelligence (AI), after providing a variety of information to cure cancer, will likely be used for reading cerebral aneurysm images.

Health Insurance Review & Assessment Service (HIRA)_{건강보험심사평가원} has recently begun to develop “AI-based diagnosis model of medical images” together with Seoul National University Hospital_{서울대병원}.

Their aim is to develop AI-reading algorism so that they can use MRI images read first by AI in medical treatments.

The researchers will use brain MRI images held by SNUH, and doctors at the hospital will label information on data.

HIRA will provide the environment, including facility and equipment, for the research as well as infrastructure to make the most of the information, including big data.

The research is part of the government project to support the utilization of public data, in which the Ministry of the Interior and Safety (MOIS)_{행정자치부} has poured budget of 890 million won ($783,000). However, it is a separate program focusing on how to utilize and open up big data.

It is also a part of the project to create new value by making the most of the healthcare big data held by HIRA. The overall project also includes a program to create next generation life and health industry ecosystem funded by the Ministry of Trade, Industry and Energy (MTIE)_{산업통상자원부} and a program to develop the support system of precision medicine hospitals financed by the Ministry of Science and ICT (MSIT)_{과학기술정보통신부}.

The said research, however, will be limited to a cerebral aneurysm. When the researchers develop the image reading algorism, they will make it public so that industrial and medical circles also can use it.

“We are cooperating with Seoul National University Hospital for reading images and developing algorism, and, if we make the algorism through AI learning of cerebral aneurysm image, doctors will be able to reduce the time for treatment,” a HIRA official said. “We will increase the added value in the future by opening up the results.”

truei@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>